Trade Cardlytics - CDLX CFD

Trading Conditions
Spread0.09
Long position overnight fee
Long position overnight fee

Margin. Your investment
US$1,000.00
Overnight fee
Charges from full value of position
-0.026179 %
(-US$1.05)

Trade size with leverage ~ US$5,000.00

Short position overnight fee ~ US$4,000.00


-0.026179%
Short position overnight fee
Short position overnight fee

Margin. Your investment
US$1,000.00
Overnight fee
Charges from full value of position
0.003957 %
(US$0.16)

Trade size with leverage ~ US$5,000.00

Short position overnight fee ~ US$4,000.00


0.003957%
Overnight fee time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin20
Stock exchangeUnited States of America
Commission on trade10%

Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close11.55
Open11.29
1-Year Change96.01%
Day's Range11.29 - 12.27

Cardlytics Company profile

About Cardlytics Inc

Cardlytics, Inc. is a digital advertising platform. The Company operates advertising platform, namely the Cardlytics platform within its own and its partners' digital channels, which include online, mobile applications, email, and various real-time notifications. It also operates a customer data platform, namely the Bridg platform, which utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers, in a privacy-protective manner, to perform analytics and targeted loyalty marketing and also enable marketers to measure the impact of their marketing. Through the Cardlytics platform, marketers can deliver advertising content to customers in the form of an opportunity to earn rewards, which are funded with a portion of the fees, which it collect from marketers. With the Cardlytics platform, it enables marketers to reach potential customers across its network of financial institutions (FI) partners through their digital banking accounts.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Cardlytics Inc revenues increased 43% to $267.1M. Net loss increased from $55.4M to $128.6M. Revenues reflect Cardlytics Direct segment increase of 38% to $258.8M, United States segment increase of 43% to $246.3M, United Kingdom segment increase of 48% to $20.8M. Higher net loss reflects Research and development expense - increase from $12.7M to $27.5M (expense).